KST
🇰🇷 KRXHealthcareMarket Closed

Celltrion

068270 · 셀트리온

₩190,000
+₩3,000 (+1.60%)

Price Chart (Mock)

About

Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.

P/E Ratio
22.7x
Market Cap
₩40.8T
52W High
₩230,000
52W Low
₩165,000
Volume
1.3M
Sector
Healthcare

⚠️ This information does not constitute investment advice. Investment decisions should be made at your own judgment and responsibility. All data and analysis provided on this platform are for reference only.